Silver sulfadiazine

Modify Date: 2024-01-02 10:34:27

Silver sulfadiazine Structure
Silver sulfadiazine structure
Common Name Silver sulfadiazine
CAS Number 22199-08-2 Molecular Weight 357.137
Density 1.496g/cm3 Boiling Point 512.6ºC at 760 mmHg
Molecular Formula C10H9AgN4O2S Melting Point 285 °C (dec.)(lit.)
MSDS Chinese USA Flash Point 263.8ºC
Symbol GHS07
GHS07
Signal Word Warning

 Use of Silver sulfadiazine


Silver sulfadiazine (AgSD), a sulfonamide antibiotic, effects a dual inhibitory action on bacterial growth by its sulfa moiety (SD-SDZ) that prevents bacterial folate absorption and subsequent DNA synthesis. The silver that is released from Silver sulfadiazine binds and disrupts the DNA structure, precluding bacterial DNA replication[1].

 Names

Name silver(1+) sulfadiazinate
Synonym More Synonyms

 Silver sulfadiazine Biological Activity

Description Silver sulfadiazine (AgSD), a sulfonamide antibiotic, effects a dual inhibitory action on bacterial growth by its sulfa moiety (SD-SDZ) that prevents bacterial folate absorption and subsequent DNA synthesis. The silver that is released from Silver sulfadiazine binds and disrupts the DNA structure, precluding bacterial DNA replication[1].
Related Catalog
In Vitro Silver sulfadiazine (AgSD) is a topical antibiotic used to the research of bacterial infection in burns[2].
References

[1]. Strydom SJ, et al. Poly(amidoamine) dendrimer-mediated synthesis and stabilization of silver sulfonamide nanoparticles with increased antibacterial activity. Nanomedicine. 2013;9(1):85-93.

[2]. Munhoz DR, et al. Alginate films functionalized with silver sulfadiazine-loaded [Mg-Al] layered double hydroxide as antimicrobial wound dressing. Int J Biol Macromol. 2019;141:504-510.

 Chemical & Physical Properties

Density 1.496g/cm3
Boiling Point 512.6ºC at 760 mmHg
Melting Point 285 °C (dec.)(lit.)
Molecular Formula C10H9AgN4O2S
Molecular Weight 357.137
Flash Point 263.8ºC
Exact Mass 355.949707
PSA 94.32000
LogP 3.11490
Vapour Pressure 1.28E-10mmHg at 25°C
Storage condition Hygroscopic, Refrigerator, Under Inert Atmosphere
Stability Stable. Incompatible with strong oxidizing agents.

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
WP1950000
CHEMICAL NAME :
Sulfanilamide, N(sup 1)-2-pyrimidinyl-, monosilver(1+) salt
CAS REGISTRY NUMBER :
22199-08-2
LAST UPDATED :
199712
DATA ITEMS CITED :
34
MOLECULAR FORMULA :
C10-H10-N4-O2-S.Ag
MOLECULAR WEIGHT :
358.17
WISWESSER LINE NOTATION :
T6N CNJ BMSWR DZ &-AG-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
536 mg/kg/21W-I
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage)
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>10 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
126 mg/kg
TOXIC EFFECTS :
Liver - other changes Blood - changes in spleen Skin and Appendages - dermatitis, other (after systemic exposure)
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>10 gm/kg
TOXIC EFFECTS :
Liver - other changes Blood - changes in spleen
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
160 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>10 gm/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - somnolence (general depressed activity) Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
550 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>10 gm/kg
TOXIC EFFECTS :
Liver - other changes Blood - changes in spleen
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
240 mg/kg/30D-C
TOXIC EFFECTS :
Endocrine - other changes Blood - changes in spleen Biochemical - Effect on specific coenzyme - not otherwise specified
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1456 mg/kg/13W-C
TOXIC EFFECTS :
Liver - other changes Blood - changes in spleen Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
728 mg/kg/26W-C
TOXIC EFFECTS :
Liver - other changes Blood - changes in spleen Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
44 gm/kg
SEX/DURATION :
female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
11 gm/kg
SEX/DURATION :
male 70 day(s) pre-mating female 2 week(s) pre-mating - 7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
11 gm/kg
SEX/DURATION :
female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
26 gm/kg
SEX/DURATION :
female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
6500 mg/kg
SEX/DURATION :
female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system

MUTATION DATA

TYPE OF TEST :
DNA inhibition
TEST SYSTEM :
Microorganism - not otherwise specified
DOSE/DURATION :
2500 ug/L
REFERENCE :
AMACCQ Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- Volume(issue)/page/year: 2,367,1972 *** REVIEWS *** ACGIH TLV-TWA 0.01 mg(Ag)/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 *** U.S. STANDARDS AND REGULATIONS *** MSHA STANDARD-air:TWA 0.01 mg(Ag)/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: 3,231,1971 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-ARAB Republic of Egypt:TWA 0.01 mg(Ag)/m3 JAN 1993 OEL-AUSTRALIA:TWA 0.01 mg(Ag)/m3 JAN 1993 OEL-BELGIUM:TWA 0.01 mg(Ag)/m3 JAN 1993 OEL-DENMARK:TWA 0.01 mg(Ag)/m3 JAN 1993 OEL-FINLAND:TWA 0.01 mg(Ag)/m3;STEL 0.03 mg(Ag)/m3;Skin JAN 1993 OEL-THE NETHERLANDS:TWA 0.01 mg(Ag)/m3 JAN 1993 OEL-THE PHILIPPINES:TWA 0.01 mg(Ag)/m3 JAN 1993 OEL-SWITZERLAND:TWA 0.01 mg(Ag)/m3 JAN 1993 OEL-UNITED KINGDOM:TWA 0.01 mg(Ag)/m3 JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X5603 No. of Facilities: 944 (estimated) No. of Industries: 9 No. of Occupations: 10 No. of Employees: 87352 (estimated) No. of Female Employees: 71312 (estimated)

 Safety Information

Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H315-H319-H335
Precautionary Statements P305 + P351 + P338
Hazard Codes Xi:Irritant
Risk Phrases R36/37/38
Safety Phrases S26-S36
RIDADR NONH for all modes of transport
WGK Germany 2
RTECS WP1950000
HS Code 2935001000

 Preparation


 Customs

HS Code 2935001000

 Articles9

More Articles
Silver sulfadiazine: an antibacterial agent for topical use in burns. A review of the literature.

Scand. J. Plast. Reconstr. Surg. 18(1) , 119-26, (1984)

Topical antibacterial treatment is of major importance in the burn patient. Silver sulfadiazine is an effective agent with low toxicity and few side effects. Deposition of silver in tissues, and absor...

[The use of a topical antibacterial agent (silver sulfadiazine) on soft-tissue wounds].

Minerva Chir. 45(9) , 677-81, (1990)

Reducing the quantitative level of bacterial contamination in an open, acute or chronic, soft tissue wound below the critical level of 10(5) bacteria per gram of viable tissue is essential to delayed ...

A review of the dosimetry of 1% silver sulfadiazine cream in burn wound treatment.

J. Burn Care Rehabil. 15(3) , 213-23, (1994)

A review of the periodical literature relating to burn topical antibacterial agents as listed in the Cumulated Index Medicus from January 1, 1965, through November 30, 1992, as well as bound volumes a...

 Synonyms

Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-, silver(1+) salt (1:1)
MFCD00072101
Silber(1+)-[(4-aminophenyl)sulfonyl](pyrimidin-2-yl)azanid
silver sulphadiazine
Silver(I) sulfadiazine
Flammazine
FLAMAZINE
Silvadene
SULFADIAZINE SILVER
Sulfanilsaeure-pyrimidin-2-ylamid,Silber(I)-Salz
silver sulfadiazinate
Dermazin
Silverol
Thermazene
benzenesulfonamide, 4-amino-N-2-pyrimidinyl-, monosilver(1+) salt
Sulfadiazine, silver (USP)
Sulfadiazine silver salt
Silver(I) sulfadiazine,Sulfadiazine silver
Silver sulfadiazine
Silver(1+) [(4-aminophenyl)sulfonyl](2-pyrimidinyl)azanide
silver,(4-aminophenyl)sulfonyl-pyrimidin-2-ylazanide
4-amino-N-pyrimidin-2-yl-benzenesulfonamide
sulfanilic acid pyrimidin-2-ylamide,silver (I)-salt
Sulfadiazine, Silver
Silver(1+) [(4-aminophenyl)sulfonyl](pyrimidin-2-yl)azanide
EINECS 244-834-5
Top Suppliers:I want be here





Get all suppliers and price by the below link:

Silver sulfadiazine suppliers


Price: ¥31/1g

Reference only. check more Silver sulfadiazine price